Arthur Y. L. Shu - Concepedia

Author

Arthur Y. L. Shu

Also Known As

A Shu, A. Shu, A. Y. L. SHU, A. Y. L. Shu, A.Y.L. Shu, ARTHUR Y.L. SHU, Ankang Shu, Arthur Shu, Arthur Y. L. Shu, Arthur Y.L Shu

Publications

Citations

H-Index

Concepts

All Affiliations

New Frontier GlaxoSmithKline (United States)South College

About

Arthur Y. L. Shu is an author at New Frontier specializing in organic chemistry, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	1.2K
2	Engineering	11	11	567
3	Natural Sciences	11	11	1.1K
4	Biochemistry	11	11	1.2K
5	Biology	1	1	18

Arthur Y. L. Shu

Publications

Citations

H-Index

Page 1

	Year	Citations
Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1<i>H</i>-indol-5-yl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK) Jeffrey M. Axten, Jesús R. Medina, Yanhong Feng, Journal of Medicinal Chemistry Chemoprevention StrategyChemical BiologyPharmaceutical ChemistryTumor BiologyMolecular Pharmacology	2012	601
Discovery of GSK2656157: An Optimized PERK Inhibitor Selected for Preclinical Development Jeffrey M. Axten, Stuart P. Romeril, Arthur Y. L. Shu, ACS Medicinal Chemistry Letters Drug Discovery ProgramTumor BiologyPhysical PropertiesMedicinal ChemistrySignaling Pathway	2013	224
Binding of a growth hormone releasing hexapeptide to specific hypothalamic and pituitary binding sites Ellen E. Codd, Arthur Y. L. Shu, Richard F. Walker Neuropharmacology Signal TransductionPituitary Binding SitesPituitary GlandHuman GrowthHypothalamus	1989	147
Some aspects of palladium-catalyzed reactions of aryl and vinylic halides with conjugated dienes in the presence of mild nucleophiles J. M. O’Connor, Barbara J. Stallman, W. G. Clark, The Journal of Organic Chemistry Chemical EngineeringPalladium-catalyzed ReactionsEngineeringAlkene MetathesisCross-coupling Reaction	1983	109
Biosynthetic studies of marine lipids. 11. Synthesis, biosynthesis, and absolute configuration of the internally branched demospongic acid, 22-methyl-5,9-octacosadienoic acid Daniel Raederstorff, Arthur Y. L. Shu, Janice E. Thompson, The Journal of Organic Chemistry Marine LipidsLipid AnalysisBiosynthesisMarine BiotechnologyEngineering	1987	85
Organoiridium catalyzed hydrogen isotope exchange: ligand effects on catalyst activity and regioselectivity Arthur Y. L. Shu, W. Chen, J. Richard Heys Journal of Organometallic Chemistry Chemical EngineeringLigand EffectsEngineeringIsotope ExchangeCatalyst Activity	1996	76
Potent, Selective, Orally Active 3-Oxo-1,4-benzodiazepine GPIIb/IIIa Integrin Antagonists James M. Samanen, Fadia E. Ali, Linda S. Barton, Journal of Medicinal Chemistry Altmetric Attention ScorePharmacotherapyExperimental PharmacologyPharmacodynamic ModelingTranslational Pharmacology	1996	72
NMR study of kinetic HH/HD/DH/DD isotope effects on the tautomerism of acetylporphyrin: evidence for a stepwise double proton transfer Martin Schlabach, Hans‐Heinrich Limbach, E. Bunnenberg, Journal of the American Chemical Society Molecular SciencesEngineeringChemical MeasurementBiochemistryDonut Icon	1993	63
Deuterium exchange labelling of substituted aromatics using [IrH<sub>2</sub>(Me<sub>2</sub>CO)<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>]BF<sub>4</sub> J. Richard Heys, Arthur Y. L. Shu, Stephen G. Senderoff, Journal of Labelled Compounds and Radiopharmaceuticals DerivativesEngineeringHeterocyclicDeuterium Exchange LabellingDeuterium Gas	1993	60
Direct tritium labeling of multifunctional compounds using organoiridium catalysis. 2. Arthur Y. L. Shu, D. Saunders, Sidney H. Levinson, Journal of Labelled Compounds and Radiopharmaceuticals Direct Tritium LabelingChemical EngineeringEngineeringOrganic ChemistryOrganometallic Catalysis	1999	55

Page 1